首页 | 本学科首页   官方微博 | 高级检索  
检索        

三氮唑核苷治疗低血压休克期的流行性出血热23例
引用本文:杜功舜,艾黎明.三氮唑核苷治疗低血压休克期的流行性出血热23例[J].中国新药与临床杂志,1991(5).
作者姓名:杜功舜  艾黎明
作者单位:湖北省天门市第一人民医院,湖北省天门市第一人民医院 天门 431700,天门 431700
摘    要:本组采用三氮唑核苷(病毒唑ribavirin)治疗流行性出血热低血压休克期的患者23例(男17例,女6例;年龄20-65yr,平均44±15yr),每日1g,疗程5d。结果:治疗组退热及血压稳定时间、少尿及多尿持续时间、尿蛋白消退及尿素氮(BUN)恢复正常时间均较对照组短(P<0.05),且未见明显副作用。

关 键 词:三氮唑核苷/治疗应用  低血压/药物疗法  休克/药物疗法  流行性出血热/药物疗法

Ribavirin in the treatment of epidemic hemorrhagic fever in hypotensive shock stage in 23 patients
DU Gong-Shun,AI Li-Ming.Ribavirin in the treatment of epidemic hemorrhagic fever in hypotensive shock stage in 23 patients[J].Chinese Journal of New Drugs and Clinical Remedies,1991(5).
Authors:DU Gong-Shun  AI Li-Ming
Abstract:Twenty-three patients (17M, 6F, age 20-65yr, 44±15yr) of hypotensive shock stage of epidemic hemorrhagic fever were treated with intravenous infusion of ribavirin 1g daily for 5 d. Nineteen patients served as control. The results showed that defervescence, to attain stable period of blood pressure, periods of oliguria and polyuria, disappearance of proteinuria and recovery of BUN to normal level were all significantly shorter than the control group, No serious adverse reactions were observed.
Keywords:ribavirin/therapeutic use  hypotension/drug therapy  shock/drug therapy  epidemic hemorrhagic fever/drng therapy  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号